Gilead has been, is, and will be here to fight alongside policymakers, nurses, clinicians and campaigners striving to stop the virus. And we stand beside every person living with HIV today, with the knowledge that we all have something to contribute.
Without relentless collaboration and partnership, we could not have come this far. With it we can move forward together, faster, ensuring we leave no one behind.
Together we can change more lives. Together we can stop the virus.
This website has been created by Gilead for the purposes of disease education and awareness.
Blood-borne viruses include HIV and viral hepatitis B and C viruses, all of which people may carry in their blood and spread by various routes. These viruses are a public health challenge across the world, including in Europe.
This website has been created by Gilead for the purposes of disease education and awareness.
Over the past thirty years, coordinated efforts of key stakeholders and treatment innovation have transformed HIV from a fatal condition into a manageable long-term condition1. Today people living with HIV can have a near-normal life expectancy.
This website has been created by Gilead for the purposes of disease education and awareness.
Over the past 12 months, Gilead Sciences has partnered with POLITICO Europe on a journalistic investigation into HIV called “Telescope: the new AIDS epidemic”.
This website has been created by Gilead for the purposes of disease education and awareness.
In an effort to fight the HIV epidemic globally, the International Association of Providers of AIDS Care IAPAC, the Joint United Nations Programme on HIV/AIDS (UNAIDS), the United Nations Human Settlements Programme (UN-Habitat) and the City of Paris, joined forces in 2014 and endorsed the Paris Declaration.
This website has been created by Gilead for the purposes of disease education and awareness.
Gilead Sciences Germany is committed to supporting national efforts to contain and ultimately end the HIV epidemic once and for all. Together with partner organizations, Gilead intends to build on the progress achieved so far, to accelerate the fight against HIV, while at the same time supporting people with HIV to live well at every stage of life.
This website has been created by Gilead for the purposes of disease education and awareness.
Those who have worked in or lived with HIV are no strangers to a pandemic and the challenges associated with the public health fight against viruses. While striving to end the HIV epidemic globally by 2030, the deadline set by the United Nations (UN) Sustainable Development Goal 3(SDGs)1, the UK has learned some lessons that are not only pertinent for HIV but for COVID-19 too.
This website has been created by Gilead for the purposes of disease education and awareness.
Despite making fewer headlines than in previous decades, the HIV epidemic in Europe is far from being a thing of the past. It will still be around to taunt us, as we learn to cope with yet another deadly virus.
This website has been created by Gilead for the purposes of disease education and awareness.
Today, HIV is no longer a death sentence. Continued scientific innovation has brought significant progress to treatment of HIV, improving the lives of people living with HIV (PLHIV) globally. Over the years, the prevalence of HIV/AIDS is evolving, and in Belgium new infections are decreasing1.
This website has been created by Gilead for the purposes of disease education and awareness.
In 2011, Gilead Sciences launched the "Pozytywnie Otwarci" (Positively Open) fellowship programme aimed at addressing the HIV knowledge gap and tackling stigma and discrimination against people living with HIV in Poland.
This website has been created by Gilead for the purposes of disease education and awareness.
Romania recently made an assessment of the past thirty years, since the breakout of a phenomenon that can be classified as an epidemiologic accident, when thousands of children in Romanian orphanages were infected with HIV. Back then, the specialists had to take unprecedented measures and test solutions to a major problem that all other countries knew too little about.
You are now leaving www.stopthevirus and visiting a new site which is not owned or controlled by Gilead Sciences Europe. Gilead Sciences Europe is therefore not responsible for your interactions with the website or the information it provides.
Cancel Follow link